Compound heterozygosity in the SPG4 gene causes hereditary spastic paraplegia

D. V K Pantakani, U. Zechner, L. Arygriou, S. Pauli, S. M. Sauter, Ashraf U. Mannan*

*Corresponding author for this work
10 Citations (Scopus)


The SPG4 gene is frequently mutated in autosomal dominant form of hereditary spastic paraplegia (HSP). We report that the compound heterozygous sequence variants S44L, a known polymorphism, and c.1687G>A, a novel mutation in SPG4 cause a severe form of HSP in a patient. The family members carrying solely c.1687G>A mutation are asymptomatic for HSP. The reverse transcriptase-polymerase chain reaction (RT-PCR) analysis revealed that the c.1687G>A mutation is a splice site mutation and causes skipping of the exon 15 of spastin. Furthermore, quantification of RT-PCR products by sequencing and quantification of allele-specific expression by pyrosequencing assay revealed that c.1687G>A is a leaky or hypomorphic splice site mutation. At the protein level, c.1687G>A mutation in SPG4 leads to E563K substitution. In ex vivo study, about 10% of cells expressing E563K mutant spastin showed filamentous expression pattern, suggesting a hypomorphic effect at the protein level. Collectively, our results suggest that S44L in association with c.1687G>A (E563K) drops the functional level of spastin below a threshold limit sufficient to manifest HSP.

Original languageEnglish
JournalClinical Genetics
Issue number3
Pages (from-to)268-272
Number of pages5
Publication statusPublished - 01.03.2008
Externally publishedYes

Research Areas and Centers

  • Research Area: Medical Genetics


Dive into the research topics of 'Compound heterozygosity in the SPG4 gene causes hereditary spastic paraplegia'. Together they form a unique fingerprint.

Cite this